The Cooper Companies (COO) Earnings Call Presentation

Financial Performance & Guidance - CooperCompanies' FY24 revenue reached $3.9 billion[6] - The company anticipates FY25 total revenue between $4.107 billion and $4.146 billion[10] - CooperVision's FY24 revenue was $2.6 billion[18], with FY25 guidance between $2.759 billion and $2.786 billion[10] - CooperSurgical's FY24 revenue was $1.29 billion[22], with FY25 guidance between $1.347 billion and $1.359 billion[10] - CooperCompanies projects organic growth of 5%-6% for FY25[10] Market Position & Growth - The global soft contact lens market is an $11 billion market[12] - CooperVision holds 26% of the contact lens market share[13] - The fertility market is estimated to be over $2 billion globally[27] and has historically grown at 5-10% annually[27] - CooperSurgical has grown through 40+ acquisitions since 1990[24] Business Segments - Toric and multifocal lenses account for 48% of CooperVision's revenue[18] - Fertility products and services comprise 40% of CooperSurgical's revenue, while office and surgical products make up 60%[22]